Brian J. Caveney, an officer of Labcorp Holdings Inc., filed a Form 144 notice on November 10, 2026, proposing the sale of 2,000 shares of common stock on the New York Stock Exchange through Fidelity Brokerage Services LLC.

Key Highlights

  • Proposed seller: Brian J. Caveney, identified in the filing as an officer of Labcorp Holdings Inc.
  • Shares proposed for sale: 2,000 shares of common stock, with an aggregate market value of $744,080.20, according to the filing.
  • Shares outstanding: Approximately 81,200,000 shares of common stock outstanding, as stated in the filing.
  • Approximate sale date: November 10, 2026, through broker Fidelity Brokerage Services LLC, 900 Salem Street, Smithfield, RI 02917.
  • Source of shares: Shares were acquired through restricted stock vestings from the issuer on five separate dates between November 5, 2021, and February 11, 2025, all classified as compensation.
  • Prior sales in past 3 months: The filing reports nothing to report for securities sold during the past three months.

Caveney's Proposed Sale: Restricted Stock Origins and Filing Details

According to the Form 144 notice filed with the U.S. Securities and Exchange Commission, Brian J. Caveney, an officer of Labcorp Holdings Inc. (NYSE:LH as the exchange listed in the filing is NYSE), proposes to sell 2,000 shares of Labcorp Holdings common stock. The filing lists an aggregate market value of $744,080.20 for the proposed sale, with approximately 81,200,000 shares of common stock outstanding at the time of the notice.

The filing discloses that the shares to be sold were acquired through five separate restricted stock vesting events from the issuer, all characterized as compensation. Those vesting dates and amounts are: 680 shares on November 5, 2021; 296 shares on February 2, 2022; 395 shares on February 4, 2022; 358 shares on March 27, 2022; and 271 shares on February 11, 2025. Each vesting transaction lists the issuer as the person from whom the securities were acquired, and each is noted as not being a gift.

The notice was signed by Jared Cook, described in the filing as "a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Brian J. Caveney." The filing states that Caveney, by virtue of this notice, represents that he "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." No prior sales during the past three months were reported.

What Was Disclosed

Labcorp Holdings Inc. officer Brian J. Caveney filed a Form 144 notice proposing to sell 2,000 shares of common stock, with an aggregate market value of $744,080.20, on November 10, 2026, through Fidelity Brokerage Services LLC. The shares originated from restricted stock vestings received as compensation between 2021 and 2025.